# CYP27B1

## Overview
CYP27B1 is a gene that encodes the enzyme cytochrome P450 family 27 subfamily B member 1, also known as 1α-hydroxylase. This enzyme is a member of the cytochrome P450 superfamily, which is involved in the metabolism of various substrates through oxidation reactions. Specifically, CYP27B1 plays a critical role in the hydroxylation of vitamin D3, converting 25-hydroxyvitamin D (calcidiol) into its active form, 1,25-dihydroxyvitamin D (calcitriol). This conversion is essential for maintaining calcium and phosphate homeostasis, impacting bone health, immune function, and other physiological processes (Hewison20001alphaHydroxylase; Bikle2018Physiologic). The enzyme is predominantly located in the mitochondria and requires interaction with other proteins, such as adrenodoxin and NADPH-adrenodoxin reductase, to facilitate its enzymatic activity (Sawada1999Enzymatic). Mutations in the CYP27B1 gene can lead to disorders such as vitamin D-dependent rickets type 1, highlighting its clinical significance in human health (Alzahrani2010A).

## Structure
CYP27B1 is a member of the cytochrome P450 superfamily, involved in the hydroxylation of vitamin D3. The primary structure of CYP27B1 consists of a sequence of amino acids forming the polypeptide chain. Its secondary structure includes 17 alpha-helices and 6 beta-strands, which contribute to its overall folding pattern similar to other soluble cytochrome P450 enzymes (Yamamoto2004Homology). The tertiary structure of CYP27B1 is crucial for its enzymatic activity, as it forms a three-dimensional conformation that includes a substrate-binding site and a heme-binding domain essential for its function (Yamamoto2004Homology). 

The enzyme is a mitochondrial protein that catalyzes the conversion of calcidiol to calcitriol, the active form of vitamin D, which is important for calcium homeostasis and other physiological processes (Maksymchuk2020Altered). CYP27B1 may undergo post-translational modifications, such as phosphorylation, which can influence its activity and stability. The enzyme also exhibits alternative splicing, which can lead to different isoforms with potentially distinct functions, although specific splice variants of CYP27B1 are not detailed in the available context (Annalora2017Alternative).

## Function
The CYP27B1 gene encodes the enzyme 1α-hydroxylase, which is crucial for converting 25-hydroxyvitamin D (25OHD) into its active form, 1,25-dihydroxyvitamin D (1,25(OH)2D). This conversion is essential for calcium and phosphate homeostasis, impacting bone health and immune function (Hewison20001alphaHydroxylase; Bikle2018Physiologic). In bone cells, CYP27B1 is expressed in chondrocytes, mesenchymal stem cells, osteoclasts, and possibly osteocytes, where it influences osteoblast and osteoclast activity, playing a role in bone cell differentiation and function (Bikle2018Physiologic). In the immune system, CYP27B1 is expressed in macrophages and dendritic cells, where it modulates immune responses by producing 1,25(OH)2D locally. This production suppresses dendritic cell maturation and promotes a tolerogenic immune environment (Bikle2018Physiologic).

In epithelial cells, such as epidermal keratinocytes, CYP27B1 contributes to maintaining the skin's barrier function by regulating epidermal proliferation and differentiation (Bikle2018Physiologic). The enzyme is also involved in the regulation of the renin-angiotensin system, influencing blood pressure and cardiac function (Bikle2018Physiologic). Overall, CYP27B1's activity is vital for maintaining various physiological processes, including cellular proliferation, differentiation, and immune function (Bikle2018Physiologic).

## Clinical Significance
Mutations in the CYP27B1 gene are associated with several diseases, most notably vitamin D-dependent rickets type 1 (VDDR-I), an autosomal recessive disorder. This condition is characterized by symptoms such as hypotonia, growth retardation, hypocalcemic seizures, and radiographic features of rickets. Mutations in CYP27B1 lead to a significant reduction or complete loss of 1α-hydroxylase activity, which is crucial for converting vitamin D into its active form, calcitriol (Demir2015Novel; Cui2012Novel; Alzahrani2010A).

Alterations in CYP27B1 expression and polymorphisms have been implicated in various cancers and chronic diseases. For instance, certain polymorphisms in CYP27B1 are associated with an increased risk of non-small cell lung cancer, particularly in smokers, and are linked to colorectal cancer risk (Latacz2020Single). Additionally, CYP27B1 polymorphisms have been associated with autoimmune diseases such as multiple sclerosis and Addison's disease, as well as congestive heart failure in patients with hypertension (Wilke2009Genetic; Ramagopalan2011Rare; Latacz2020Single).

These findings highlight the clinical significance of CYP27B1 in various pathological conditions, emphasizing the importance of this gene in maintaining vitamin D homeostasis and its broader implications in human health.

## Interactions
CYP27B1 interacts with several proteins that are crucial for its enzymatic function. It forms a functional complex with adrenodoxin (ADX) and NADPH-adrenodoxin reductase (ADR) in Escherichia coli, which is essential for its enzymatic activity. This interaction facilitates efficient electron transfer from NADPH through ADR and ADX to CYP27B1, enhancing its 1α-hydroxylase activity (Sawada1999Enzymatic). 

The interaction between CYP27B1 and ADX involves specific amino acid residues, particularly arginine 458 (Arg458) in mouse CYP27B1. This residue is important for forming electrostatic interactions with the negatively charged surface of ADX, which is crucial for electron transfer and catalytic efficiency. Mutations at Arg458, such as R458K and R458Q, significantly affect the enzyme's catalytic activity and electron transfer efficiency, indicating the importance of this residue in the interaction (Urushino2006Interaction).

These interactions highlight the role of ADX and ADR as both electron donors and effectors in the enzymatic function of CYP27B1, emphasizing the importance of specific residues in maintaining the structural and functional integrity of the enzyme (Urushino2006Interaction).


## References


[1. (Sawada1999Enzymatic) Natsumi Sawada, Toshiyuki Sakaki, Sachiko Kitanaka, Ken‐ichi Takeyama, Shigeaki Kato, and Kuniyo Inouye. Enzymatic properties of human 25‐hydroxyvitamin d3 1α‐hydroxylase: coexpression with adrenodoxin and nadph–adrenodoxin reductase in escherichia coli. European Journal of Biochemistry, 265(3):950–956, November 1999. URL: http://dx.doi.org/10.1046/j.1432-1327.1999.00794.x, doi:10.1046/j.1432-1327.1999.00794.x. This article has 52 citations.](https://doi.org/10.1046/j.1432-1327.1999.00794.x)

[2. (Urushino2006Interaction) Naoko Urushino, Keiko Yamamoto, Norio Kagawa, Shinichi Ikushiro, Masaki Kamakura, Sachiko Yamada, Shigeaki Kato, Kuniyo Inouye, and Toshiyuki Sakaki. Interaction between mitochondrial cyp27b1 and adrenodoxin: role of arginine 458 of mouse cyp27b1. Biochemistry, 45(14):4405–4412, March 2006. URL: http://dx.doi.org/10.1021/bi060072o, doi:10.1021/bi060072o. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi060072o)

[3. (Alzahrani2010A) Ali S. Alzahrani, Minjing Zou, Essa Y. Baitei, Omalkhaire M. Alshaikh, Roua A. Al-Rijjal, Brian F. Meyer, and Yufei Shi. A novel g102e mutation of cyp27b1 in a large family with vitamin d-dependent rickets type 1. The Journal of Clinical Endocrinology &amp; Metabolism, 95(9):4176–4183, September 2010. URL: http://dx.doi.org/10.1210/jc.2009-2278, doi:10.1210/jc.2009-2278. This article has 41 citations.](https://doi.org/10.1210/jc.2009-2278)

[4. (Demir2015Novel) Korcan Demir, Walaa E. Kattan, Minjing Zou, Erdem Durmaz, Huda BinEssa, Özlem Nalbantoğlu, Roua A. Al-Rijjal, Brian Meyer, Behzat Özkan, and Yufei Shi. Novel cyp27b1 gene mutations in patients with vitamin d-dependent rickets type 1a. PLOS ONE, 10(7):e0131376, July 2015. URL: http://dx.doi.org/10.1371/journal.pone.0131376, doi:10.1371/journal.pone.0131376. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0131376)

[5. (Hewison20001alphaHydroxylase) M Hewison, D Zehnder, R Bland, and PM Stewart. 1alpha-hydroxylase and the action of vitamin d. Journal of Molecular Endocrinology, 25(2):141–148, October 2000. URL: http://dx.doi.org/10.1677/jme.0.0250141, doi:10.1677/jme.0.0250141. This article has 159 citations and is from a peer-reviewed journal.](https://doi.org/10.1677/jme.0.0250141)

[6. (Annalora2017Alternative) Andrew J. Annalora, Craig B. Marcus, and Patrick L. Iversen. Alternative splicing in the cytochrome p450 superfamily expands protein diversity to augment gene function and redirect human drug metabolism. Drug Metabolism and Disposition, 45(4):375–389, February 2017. URL: http://dx.doi.org/10.1124/dmd.116.073254, doi:10.1124/dmd.116.073254. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/dmd.116.073254)

[7. (Latacz2020Single) Maria Latacz, Jadwiga Snarska, Elżbieta Kostyra, Ewa Fiedorowicz, Huub F. J. Savelkoul, Roman Grzybowski, and Anna Cieślińska. Single nucleotide polymorphisms in 25-hydroxyvitamin d3 1-alpha-hydroxylase (cyp27b1) gene: the risk of malignant tumors and other chronic diseases. Nutrients, 12(3):801, March 2020. URL: http://dx.doi.org/10.3390/nu12030801, doi:10.3390/nu12030801. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/nu12030801)

[8. (Bikle2018Physiologic) Daniel D. Bikle, Sophie Patzek, and Yongmei Wang. Physiologic and pathophysiologic roles of extra renal cyp27b1: case report and review. Bone Reports, 8:255–267, June 2018. URL: http://dx.doi.org/10.1016/j.bonr.2018.02.004, doi:10.1016/j.bonr.2018.02.004. This article has 76 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bonr.2018.02.004)

[9. (Maksymchuk2020Altered) Oksana V. Maksymchuk and Vladimir I. Kashuba. Altered expression of cytochrome p450 enzymes involved in metabolism of androgens and vitamin d in the prostate as a risk factor for prostate cancer. Pharmacological Reports, 72(5):1161–1172, July 2020. URL: http://dx.doi.org/10.1007/s43440-020-00133-y, doi:10.1007/s43440-020-00133-y. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s43440-020-00133-y)

[10. (Cui2012Novel) Ningyi Cui, Weibo Xia, Hua Su, Li Pang, Yan Jiang, Yue Sun, Min Nie, Xiaoping Xing, Mei Li, Ou Wang, Tao Yuan, Yue Chi, Yingying Hu, Huaicheng Liu, Xunwu Meng, and Xueying Zhou. Novel mutations of cyp27b1 gene lead to reduced activity of 1α-hydroxylase in chinese patients. Bone, 51(3):563–569, September 2012. URL: http://dx.doi.org/10.1016/j.bone.2012.05.006, doi:10.1016/j.bone.2012.05.006. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bone.2012.05.006)

[11. (Yamamoto2004Homology) Keiko Yamamoto, Hiroyuki Masuno, Natsumi Sawada, Toshiyuki Sakaki, Kuniyo Inouye, Masaji Ishiguro, and Sachiko Yamada. Homology modeling of human 25-hydroxyvitamin d3 1α-hydroxylase (cyp27b1) based on the crystal structure of rabbit cyp2c5. The Journal of Steroid Biochemistry and Molecular Biology, 89–90:167–171, May 2004. URL: http://dx.doi.org/10.1016/j.jsbmb.2004.03.098, doi:10.1016/j.jsbmb.2004.03.098. This article has 24 citations.](https://doi.org/10.1016/j.jsbmb.2004.03.098)

[12. (Ramagopalan2011Rare) Sreeram V. Ramagopalan, David A. Dyment, M. Zameel Cader, Katie M. Morrison, Giulio Disanto, Julia M. Morahan, Antonio J. Berlanga‐Taylor, Adam Handel, Gabriele C. De Luca, A. Dessa Sadovnick, Pierre Lepage, Alexandre Montpetit, and George C. Ebers. Rare variants in the cyp27b1 gene are associated with multiple sclerosis. Annals of Neurology, 70(6):881–886, December 2011. URL: http://dx.doi.org/10.1002/ana.22678, doi:10.1002/ana.22678. This article has 186 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.22678)

[13. (Wilke2009Genetic) Russell A Wilke, Robert U Simpson, Bickol N Mukesh, Satya V Bhupathi, Richard A Dart, Nader R Ghebranious, and Catherine A McCarty. Genetic variation in cyp27b1 is associated with congestive heart failure in patients with hypertension. Pharmacogenomics, 10(11):1789–1797, November 2009. URL: http://dx.doi.org/10.2217/pgs.09.101, doi:10.2217/pgs.09.101. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.2217/pgs.09.101)